Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Industry News > Eye health entrepreneur named one of the most influential people in life sciences industry
  • Industry News

Eye health entrepreneur named one of the most influential people in life sciences industry

Ophthalmology 360

Scott Tannenbaum, Founder and Chief Executive Officer of MYZE, a digitally-native platform that offers customized daily eye care routines, was announced as a winner of PM360’s 8th Annual ELITE Awards.

The awards recognize the most influential people in the healthcare and life sciences industries. Mr Tannenbaum won in the Entrepreneurs category.

“We congratulate Scott on this recognition and for keenly listening to our colleagues and patients. As physicians, we want to continually address the needs of dry eye sufferers, and now more than ever before there is an enormous unmet need for patient-focused support and ongoing management tools,” said Cynthia Matossian, MD, FACS, Chair of the MYZE Medical Advisory Board, President of the American College of Eye Surgeons (ACES), and Founder and Partner of the American College of Eye Technicians (ACET) in a press release. “We know that there is a tsunami of dry eye disease and digital eye strain coming.  People are spending more and more of their time on computers and utilizing multiple screens throughout the day and we know the face of dry eye is changing. It is exciting to chaperone the emergence of MYZE, as it is my contention that earlier intervention and ongoing management can only assist in improving outcomes and quality of life for those suffering from dry eye and other ocular surface related issues.”

“We plan on transforming the Eye Health patient experience by helping make eye care part of everyone’s daily self care routine,” said Scott Tannenbaum, Founder of MYZE in a statement.  “I want to ensure that all patients and providers using our platform have magical moments and memorable experiences.  This begins with a patient centric, yet scientifically-rigorous approach to screen for dry eye, providing access to highly-personalized, affordable, and expert-recommended daily routines, along with novel disease-state education, daily inspiration, tracking and monitoring, as well as providing connectivity to some of the most influential eye care professionals in the United States.”

See the full list of winners here.

Share

Related Content

  • Retina

Heidelberg receives FDA clearance for updated SPECTRALIS software

FDA approves Beovu label update to include safety information
  • Cataract

FDA approves first and only extended depth of focus IOL for cataract patients

  • Retina Care 360

Phase 3 SOL-1 trial results are a “landmark achievement” for investigational TKI therapy for wet AMD

  • Industry News

Topcon Healthcare partners with RemoniHealth on remote eye care

1 Min Read
  • Cornea and External Disease

DefEYE Inc launches as independent ophthalmic biologics company

  • Industry News

Harrow to acquire Melt Pharmaceuticals to expand non-opioid sedation options

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon